Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy

European Journal of Health Economics

Volumn 12, Issue 3, 2011, Pages 205-218

  Wille, Eberhard ^a   Scholze, Jürgen ^b   Alegria, Eduardo ^c   Ferri, Claudio ^d   Langham, Sue ^e   Stevens, Warren ^f   Jeffries, David ^g   Uhl Hochgraeber, Kerstin ^h  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Servicio de Cardiologia   (Spain)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e Independent Health Economist   (United Kingdom)

^f Independent Health Economist   (United States)

^g MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^h BAYER PHARMA AG   (Germany)

Author keywords

Cost of illness; Health care costs; Hypertension; Metabolic syndrome; Prevalence

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; COST OF ILLNESS; DEMOGRAPHY; ECONOMIC ASPECT; EDUCATION PROGRAM; GERMANY; HEALTH CARE COST; HEALTH SERVICE; HUMAN; HYPERTENSION; ITALY; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPAIN;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GERMANY; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; ITALY; METABOLIC SYNDROME X; MODELS, ECONOMIC; PREVALENCE; RISK FACTORS; SPAIN;

EID: 79958237659     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-010-0223-9     Document Type: Article

References (64)

1. R Kahn J Buse E Ferrannini M Stern 2005 The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the European association for the study of diabetes Diabetes Care 28 9 2289 2304 16123508 10.2337/diacare.28.9.2289 (Pubitemid 41242486)
2. ES Ford 2005 Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 7 1769 1778 15983333 10.2337/diacare.28.7.1769 (Pubitemid 40923091)
3. A Galassi K Reynolds J He 2006 Metabolic syndrome and risk of cardiovascular disease: a meta-analysis Am. J. Med. 119 10 812 819 17000207 10.1016/j.amjmed.2006.02.031 1:CAS:528:DC%2BD28XpvFemtrk%3D (Pubitemid 44415613)
4. N Sattar A Gaw O Scherbakova I Ford DS O'Reilly SM Haffner C Isles PW Macfarlane CJ Packard SM Cobbe J Shepherd 2003 Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study Circulation 108 4 414 419 12860911 10.1161/01.CIR.0000080897.52664.94 1:CAS:528:DC%2BD3sXlsFOjt7s%3D (Pubitemid 36935533)
5. B Isomaa P Almgren T Tuomi B Forsen K Lahti M Nissen MR Taskinen L Groop 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 4 683 689 11315831 10.2337/diacare.24.4.683 1:STN:280:DC%2BD3MvjsVOqsw%3D%3D (Pubitemid 32893993)
6. SM Rodriguez-Colon J Mo Y Duan J Liu JE Caulfield X Jin D Liao 2009 Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study Stroke 40 1 200 205 18927451 10.1161/STROKEAHA.108.523035
7. G Schillaci M Pirro G Vaudo F Gemelli S Marchesi C Porcellati E Mannarino 2004 Prognostic value of the metabolic syndrome in essential hypertension J. Am. Coll. Cardiol. 43 10 1817 1822 15145106 10.1016/j.jacc.2003.12.049 (Pubitemid 38622521)
8. EA Andreadis GI Tsourous CK Tzavara DX Georgiopoulos PM Katsanou GE Marakomichelakis EJ Diamantopoulos 2007 Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population Am. J. Hypertens. 20 5 558 564 17485022 10.1016/j.amjhyper.2006.12. 001 (Pubitemid 46678707)
9. SD Pierdomenico D Lapenna R Di Tommaso S Di Carlo MP Caldarella M Neri A Mezzetti F Cuccurullo 2007 Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk Am. J. Hypertens. 20 12 1291 1296 18047919 10.1016/j.amjhyper.2007.06.011 (Pubitemid 350151685)
10. J Segura JR Banegas JA Garcia-Donaire F Rodriguez-Artalejo JJ de la Cruz M Praga LM Ruilope 2007 Should hypertension guidelines be changed for hypertensive patients with the metabolic syndrome? J. Clin. Hypertens. (Greenwich.) 9 8 595 600 10.1111/j.1524-6175.2007.06522.x 1:CAS:528: DC%2BD2sXpsVCks7Y%3D
11. J Redon R Cifkova S Laurent P Nilsson K Narkiewicz S Erdine G Mancia 2008 The metabolic syndrome in hypertension: European society of hypertension position statement J. Hypertens. 26 10 1891 1900 18806611 10.1097/HJH. 0b013e328302ca38 1:CAS:528:DC%2BD1cXhtFCju7%2FN
12. G Mancia G De Backer A Dominiczak R Cifkova R Fagard G Germano G Grassi AM Heagerty SE Kjeldsen S Laurent K Narkiewicz L Ruilope A Rynkiewicz RE Schmieder HA Struijker Boudier A Zanchetti A Vahanian J Camm R De Caterina V Dean K Dickstein G Filippatos C Funck-Brentano I Hellemans SD Kristensen K McGregor U Sechtem S Silber M Tendera P Widimsky JL Zamorano SE Kjeldsen S Erdine K Narkiewicz W Kiowski E Agabiti-Rosei E Ambrosioni R Cifkova A Dominiczak R Fagard AM Heagerty S Laurent LH Lindholm G Mancia A Manolis PM Nilsson J Redon RE Schmieder HA Struijker-Boudier M Viigimaa G Filippatos S Adamopoulos E Agabiti-Rosei E Ambrosioni V Bertomeu D Clement S Erdine C Farsang D Gaita W Kiowski G Lip JM Mallion AJ Manolis PM Nilsson E O'Brien P Ponikowski J Redon F Ruschitzka J Tamargo P van Zwieten M Viigimaa B Waeber B Williams JL Zamorano 2007 The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J. 28 12 1462 1536 17562668
13. A Cordero M Laclaustra M Leon A Grima JA Casasnovas E Luengo A del Rio I Ferreira E Alegria 2006 Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A metabolic syndrome in active subjects in Spain (MESYAS) registry substudy Am. J. Hypertens. 19 2 189 196 16448891 10.1016/j.amjhyper.2005.08.018 1:CAS:528:DC%2BD28XhtFWitbg%3D (Pubitemid 43350172)
14. LA Ferrara O Cardoni M Mancini A Zanchetti 2007 Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the gubbio study J. Hum. Hypertens. 21 10 795 801 17508012 10.1038/sj.jhh.1002232 1:STN:280:DC%2BD2srmtVaguw%3D%3D (Pubitemid 47450005)
15. G Mancia G Parati C Borghi G Ghironzi E Andriani L Marinelli M Valentini F Tessari E Ambrosioni 2006 Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study J. Hypertens. 24 5 837 843 16612244 10.1097/01.hjh.0000222752. 67572.61 1:CAS:528:DC%2BD28XjsVeltLk%3D (Pubitemid 43670453)
16. G Mancia M Bombelli G Corrao R Facchetti F Madotto C Giannattasio FQ Trevano G Grassi A Zanchetti R Sega 2007 Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis Hypertension 49 1 40 47 17130308 10.1161/01.HYP.0000251933.22091.24 1:CAS:528:DC%2BD28XhtlSrs7nN (Pubitemid 46360339)
17. V Barrios C Escobar A Calderon JL Llisterri E Alegria J Muniz A Matali 2007 Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis J. Cardiometab. Syndr. 2 1 9 15 17684454 10.1111/j.1559-4564.2007.06313.x 1:CAS:528: DC%2BD2sXlslWnt7w%3D
18. R Romero J Bonet A de la Sierra MT Aguilera I Esopoh Study 2007 Undiagnosed obesity in hypertension: clinical and therapeutic implications Blood Press. 16 6 347 353 18058454 10.1080/08037050701715117 (Pubitemid 350226716)
19. J Navarro J Redon L Cea-Calvo JV Lozano C Fernandez-Perez A Bonet J Gonzalez-Esteban 2007 Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study Blood Press. 16 1 20 27 17453748 10.1080/08037050701217817 (Pubitemid 46679444)
20. A de la Sierra R Romero J Bonet M Perez JS Lopez R Ravella MT Aguilera 2006 Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population Med. Clin. (Barc.) 126 11 406 409 10.1157/13086123
21. SE Kjeldsen L Naditch-Brule S Perlini W Zidek C Farsang 2008 Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the global cardiometabolic risk profile in patients with hypertension disease survey J. Hypertens. 26 10 2064 2070 18806632 10.1097/HJH.0b013e32830c45c3 1:CAS:528:DC%2BD1cXhtFCju73O
22. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults.: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106, (25):3143-421 (2002)
23. Robert Koch Institute: Public use file BGS98, german national health interview and examination survey 1998. Robert Koch Institute, Berlin (2000)
24. R Perez-Fernandez AF Marino C Cadarso-Suarez MA Botana MA Tome I Solache A Rego-Iraeta AJ Mato 2007 Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases J. Hum. Hypertens. 21 5 366 373 17301825 1:STN:280:DC%2BD2s3jt1CitA%3D%3D (Pubitemid 46637943)
25. G Mancia R Volpe S Boros M Ilardi C Giannattasio 2004 Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care J. Hypertens. 22 1 51 57 15106794 10.1097/00004872-200401000- 00012 1:CAS:528:DC%2BD2cXivFyquro%3D (Pubitemid 38293530)
26. H Neuhauser U Ellert 2008 Estimation of the metabolic syndrome prevalence in the general population in Germany J. Public Health 16 221 227 10.1007/s10389-007-0168-3
27. M Volpe G Tocci B Trimarco EA Rosei C Borghi E Ambrosioni A Menotti A Zanchetti G Mancia 2007 Blood pressure control in Italy: results of recent surveys on hypertension J. Hypertens. 25 7 1491 1498 17563573 10.1097/HJH.0b013e3280fa83a6 1:CAS:528:DC%2BD2sXmtlWntrc%3D (Pubitemid 46918838)
28. K Wolf-Maier RS Cooper JR Banegas S Giampaoli HW Hense M Joffres M Kastarinen N Poulter P Primatesta F Rodriguez-Artalejo B Stegmayr M Thamm J Tuomilehto D Vanuzzo F Vescio 2003 Hypertension prevalence and blood pressure levels in 6 European Countries, Canada, and the United States JAMA 289 18 2363 2369 12746359 10.1001/jama.289.18.2363 (Pubitemid 37430168)
29. R Gabriel M Alonso A Segura MJ Tormo LM Artigao JR Banegas C Brotons R Elosua A Fernandez-Cruz J Muniz B Reviriego F Rigo 2008 Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE study Rev. Esp. Cardiol. 61 10 1030 1040 18817679
30. Datamonitor: Stakeholder insight: metabolic syndrome. Datamonitor, New York (2004)
31. H Frericks J Kievit JM van Baalen JH van Bockel 1998 Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature Stroke 29 1 244 250 9445358 1:STN:280:DyaK1c7gs1WgtA%3D%3D (Pubitemid 28046971)
32. OECD: OECD health data 2007: statistics and indicators for 30 countries. OECD, Paris (2007)
33. UM Steckelings M Stoppelhaar AM Sharma HU Wittchen P Krause B Kupper W Kirch D Pittrow E Ritz B Goke H Lehnert D Tschope M Hofler H Pfister T Unger 2004 HYDRA: possible determinants of unsatisfactory hypertension control in german primary care patients Blood Press. 13 2 80 88 15182110 10.1080/08037050310030982 (Pubitemid 38607703)
34. J Dunbar-Jacob JA Erlen EA Schlenk CM Ryan SM Sereika WM Doswell 2000 Adherence in chronic disease Annu. Rev. Nurs. Res. 18 48 90 10918932 1:STN:280:DC%2BD3M%2FivF2msA%3D%3D
35. G Corrao A Zambon A Parodi E Poluzzi I Baldi L Merlino G Cesana G Mancia 2008 Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy J. Hypertens. 26 4 819 824 18327094 10.1097/HJH.0b013e3282f4edd7 1:CAS:528:DC%2BD1cXivFyjs7s%3D (Pubitemid 351354932)
36. JJ Caro M Salas JL Speckman G Raggio JD Jackson 1999 Persistence with treatment for hypertension in actual practice CMAJ 160 1 31 37 9934341 1:STN:280:DyaK1M7jtlWjtg%3D%3D (Pubitemid 29054224)
37. LD Esposti M Di Martino S Saragoni A Sgreccia A Capone S Buda ED Esposti 2004 Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies J. Clin. Hypertens. (Greenwich.) 6 2 76 84 10.1111/j.1524-6175.2004.03044.x
38. G Mazzaglia LG Mantovani MC Sturkenboom A Filippi G Trifiro C Cricelli O Brignoli AP Caputi 2005 Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care J. Hypertens. 23 11 2093 2100 16208153 10.1097/01.hjh.0000186832.41125.8a 1:CAS:528:DC%2BD2MXhtVOitLbE (Pubitemid 41830406)
39. A Cordero M Laclaustra M Leon JA Casasnovas A Grima E Luengo B Ordonez C Bergua M Bes I Pascual E Alegria 2008 Comparison of serum lipid values in subjects with and without the metabolic syndrome Am. J. Cardiol. 102 4 424 428 18678299 10.1016/j.amjcard.2008.03.079 1:CAS:528:DC%2BD1cXpsVagsro%3D
40. A Gandjour SA Stock 2007 National hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness Health Policy 83 2-3 257 267 17335933 10.1016/j.healthpol. 2007.01.003 (Pubitemid 47259206)
41. J Rovira X Badia H Pardell 1992 Cost of hypertension in Spain J. Hum. Hypertens. 6 6 481 483 1296013 1:STN:280:DyaK3s3gsVWmtA%3D%3D (Pubitemid 23064415)
42. L Hansson A Lloyd P Anderson Z Kopp 2002 Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe Blood Press. 11 1 35 45 11926349 10.1080/080370502753543945 (Pubitemid 34257355)
43. NS Breekveldt-Postma FJ Penning-van Beest SJ Siiskonen H Falvey G Vincze OH Klungel RM Herings 2008 The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke Curr. Med. Res. Opin. 24 1 121 127 18031596 (Pubitemid 351160245)
44. D Noto CM Barbagallo AB Cefalu A Falletta M Sapienza G Cavera S Amato M Pagano M Maggiore A Carroccio A Notarbartolo MR Averna 2008 The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a mediterranean population Atherosclerosis 197 1 147 153 17466306 10.1016/j.atherosclerosis.2007.03.005 1:CAS:528:DC%2BD1cXisVSmu7w%3D (Pubitemid 351278405)
45. J Mar F Rodriguez-Artalejo 2001 Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? J. Hypertens. 19 1 149 155 11204296 10.1097/00004872- 200101000-00020 1:CAS:528:DC%2BD3MXns1Oqsg%3D%3D (Pubitemid 32099288)
46. MJ Taylor PA Scuffham PL McCollam DE Newby 2007 Acute coronary syndromes in Europe: 1-year costs and outcomes Curr. Med. Res. Opin. 23 3 495 503 17355731 10.1185/030079906X167462 (Pubitemid 46456897)
47. CD Mullins M Sikirica V Seneviratne J Ahn KS Akhras 2004 Comparisons of hypertension-related costs from multinational clinical studies Pharmacoeconomics 22 15 1001 1014 15449964 10.2165/00019053-200422150-00004 (Pubitemid 39472625)
48. WJ Elliott PM Meyer 2007 Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis Lancet 369 9557 201 207 17240286 10.1016/S0140-6736(07)60108-1 1:CAS:528:DC%2BD2sXntlCnsA%3D%3D (Pubitemid 46111014)
49. B Jonsson 2002 Revealing the cost of type ii diabetes in Europe Diabetologia 45 7 S5 S12 12136405 10.1007/s00125-002-0858-x 1:STN:280: DC%2BD38zoslemtw%3D%3D
50. Berghofer, A., Pischon, T., Reinhold, T., Apovian, C.M., Sharma, A.M., Willich, S.N.: Obesity prevalence from a european perspective: a systematic review. BMC Public Health 8, 200 (2008) schemas-com.
51. International Association for the Study of Obesity.: Adult overwieght and obesity in EU 27. http://www.iotf.org/database/documents/ AdultEU27January2009pdf.pdf. (2009)
52. LH Curtis BG Hammill MA Bethel KJ Anstrom JS Gottdiener KA Schulman 2007 Costs of the metabolic syndrome in elderly individuals: findings from the cardiovascular health study Diabetes Care 30 10 2553 2558 17623825 10.2337/dc07-0460 (Pubitemid 47547792)
53. DM Boudreau DC Malone MA Raebel PA Fishman GA Nichols AC Feldstein AN Boscoe RH Ben Joseph DJ Magid LJ Okamoto 2009 Health care utilization and costs by metabolic syndrome risk factors Metab. Syndr. Relat. Disord. 7 4 305 314 19558267 10.1089/met.2008.0070 1:STN:280:DC%2BD1MrislWksQ%3D%3D
54. RH Eckel DA York S Rossner V Hubbard I Caterson ST St Jeor LL Hayman RM Mullis SN Blair 2004 Prevention conference vii: obesity, a worldwide epidemic related to heart disease and stroke: executive summary Circulation 110 18 2968 2975 15520336 10.1161/01.CIR.0000140086.88453.9A (Pubitemid 39473624)
55. S Luders F Hammersen A Kulschewski U Venneklaas C Zuchner A Gansz M Schnieders E Pfarr CD Sturm WD Paar J Schrader 2005 Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice Int. J. Clin. Pract. 59 6 632 638 15924589 10.1111/j.1742-1241.2005.00518.x 1:STN:280:DC%2BD2M3otVGruw%3D%3D (Pubitemid 44192631)
56. C Lonati A Morganti L Comarella G Mancia A Zanchetti 2008 Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (Dia)bete study J. Hypertens. 26 9 1801 1808 18698215 10.1097/HJH.0b013e328307a07f 1:CAS:528:DC%2BD1cXpvFynsLY%3D
57. A Maetzel LC Li J Pencharz G Tomlinson C Bombardier 2004 The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study Ann. Rheum. Dis. 63 4 395 401 15020333 10.1136/ard.2003. 006031 1:STN:280:DC%2BD2c7ntlKmsw%3D%3D (Pubitemid 38453305)
58. U Kiiskinen E Vartiainen P Puska A Aromaa 1998 Long-term cost and life-expectancy consequences of hypertension J. Hypertens. 16 8 1103 1112 9794712 10.1097/00004872-199816080-00004 1:STN:280:DyaK1M%2FgvVynsQ%3D%3D (Pubitemid 28334010)
59. AS Gami BJ Witt DE Howard PJ Erwin LA Gami VK Somers VM Montori 2007 Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J. Am. Coll. Cardiol. 49 4 403 414 17258085 10.1016/j.jacc.2006.09.032 1:CAS:528: DC%2BD2sXhtVCks7s%3D (Pubitemid 46135879)
60. L Roux C Donaldson 2004 Economics and obesity: costing the problem or evaluating solutions? Obes. Res. 12 2 173 179 14981208 10.1038/oby.2004.23 (Pubitemid 41132539)
61. National Institute for Health and Clinical Excellence.: CG34: hypertension: NICE clinical guidelines. National Institute for Health and Clinical Excellence, London (2006)
62. G Mancia S Laurent E Agabiti-Rosei E Ambrosioni M Burnier MJ Caulfield R Cifkova D Clement A Coca A Dominiczak S Erdine R Fagard C Farsang G Grassi H Haller A Heagerty SE Kjeldsen W Kiowski JM Mallion A Manolis K Narkiewicz P Nilsson MH Olsen KH Rahn J Redon J Rodicio L Ruilope RE Schmieder HA Struijker-Boudier PA Van Zwieten M Viigimaa A Zanchetti 2009 Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document Blood Press. 18 6 308 347 20001654 10.3109/08037050903450468 1:CAS:528:DC%2BD1MXhsFOns73O
63. J Mathes K Kostev A Gabriel O Pirk RE Schmieder 2008 Risks and costs of the first hypertension-associated event, compliance and persistence in niave hypertensive patients after initiating monotherapy Value Health 11 A415 10.1016/S1098-3015(10)66406-6
64. TW Kurtz 2006 New treatment strategies for patients with hypertension and insulin resistance Am. J. Med. 119 Suppl 1 S24 S30 16563944 10.1016/j.amjmed.2006.01.011